CLINICAL TRIALS PROFILE FOR SACROSIDASE
✉ Email this page to a colleague
All Clinical Trials for sacrosidase
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02784067 ↗ | A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency | Withdrawn | QOL Medical, LLC | Phase 4 | 2016-05-01 | S09A is a Phase 4, multicenter, randomized, double-blind, placebo-controlled, parallel study examining the efficacy and safety of a Sucraid (sacrosidase) Oral Solution in comparison to a placebo in 150-200 subjects with chronic diarrhea possibly attributable to sucrase deficiency. |
NCT05703009 ↗ | Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance | Not yet recruiting | QOL Medical, LLC | Phase 2 | 2023-02-28 | SSDXA-14 is a Phase 2 (feasibility/pilot) double-blind, placebo-controlled, crossover study to evaluate the efficacy and safety of sacrosidase and placebo in 25 subjects objectively diagnosed with fructan intolerance. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for sacrosidase
Condition Name
Clinical Trial Progress for sacrosidase
Clinical Trial Phase
Clinical Trial Sponsors for sacrosidase
Sponsor Name